2/13/2024 | BKCVIG | S&P changes Ares outlook to positive
|
1/31/2024 | CV | Market Commentary: Rocket Lab, Barclays synthetic on deck; Immunocore in demand, jumps on trading debut
|
1/16/2024 | BKCVIG | S&P rates Ares Capital notes BBB-
|
1/3/2024 | CV | Market Commentary: OPKO reopens primary; high-grade convertibles eyed; PG&E active; MicroStrategy lower
|
9/18/2023 | BKCVIG | Moody’s changes Ares outlook to positive
|
8/3/2023 | BKCVIG | Fitch assigns BBB to Ares Capital notes
|
7/27/2023 | BKCVIG | S&P rates Ares Capital notes due 2027 BBB-
|
7/27/2022 | CV | Market Commentary: Convertibles secondary sees post-Fed ‘lift-a-thon’; Ares eyed; Enphase, Guidewire up
|
7/27/2022 | CV | Market Commentary: Morning Commentary: Ares Capital convertibles in focus in early trading post-earnings
|
1/7/2022 | CV | Market Commentary: Ares Capital convertibles dominate trading; Western Digital up; Avalara, Bill.com active
|
1/7/2022 | CV | Market Commentary: Morning Commentary: Ares Capital convertibles eyed on end-of-life trade; Bill.com active
|
1/5/2022 | CV | Market Commentary: Convertibles secondary soft amid stock sell-off; Ares Capital active; Affirm, Lucid down
|
1/5/2022 | CV | Market Commentary: Morning Commentary: Ares Capital convertibles active as maturity approaches; Affirm down
|
1/19/2021 | CV | Market Commentary: Convertibles primary, secondary markets quiet; Lumentum trades down outright; Nio gains
|
1/6/2021 | BKCVIG | S&P gives Ares notes BBB-
|
9/14/2020 | CV | Market Commentary: Neurocrine Biosciences convertible notes gain; Ares Capital, Western Digital active
|
9/14/2020 | CV | Market Commentary: Morning Commentary: Ares Capital, Neurocrine Biosciences convertible notes active
|
8/3/2020 | CV | Market Commentary: Convertibles primary market quiet; Southwest Airlines eyed; cruise lines down outright
|
8/3/2020 | CV | Market Commentary: Convertibles: Primary market quiet at open; investment-grade convertibles active early
|
7/8/2020 | BKCVIG | S&P rates Ares notes BBB-
|
3/24/2020 | BKCVIG | S&P revises Ares Capital view to stable
|
3/11/2020 | CV | Market Commentary: Selling pressure hits convertible secondary; high-grade paper active; recent deals tank
|
3/11/2020 | CV | Market Commentary: Morning Commentary: Trading light amid volatility; Ares active; recent deals struggle
|
1/8/2020 | BKCVIG | S&P assigns Ares notes BBB-
|
12/24/2019 | CV | Market Commentary: Convertibles trading grinds to a halt; Ares Capital active; Acorda flat after exchange
|
11/18/2019 | CV | Market Commentary: Illumina convertibles slip in active trade; Chefs’ Warehouse plans $130 million offering
|
11/18/2019 | CV | Market Commentary: Morning Commentary: Convertibles trade quietly; Becton Dickinson, Ares Capital active
|
7/24/2019 | BKCVIG | S&P revises Ares outlook to positive
|
7/9/2019 | CV | Market Commentary: Tesla in focus, comes in; Nio on the rise; Qudian jumps; Ares Capital active; Chegg improves
|
7/9/2019 | CV | Market Commentary: Morning Commentary: Convertibles trading volume light; Ares Capital, Chegg active
|
6/6/2019 | BKCVIG | Moody's rates Ares capital notes Baa3
|
6/5/2019 | CV | Market Commentary: Coupa on tap; Altair Engineering looks cheap; Q2 Holdings upsizes, tightens talk
|
6/5/2019 | BKCVIG | S&P rates Ares Capital notes BBB-
|
3/20/2019 | CV | Ares greenshoe exercised, lifts 4.625% convertibles to $402.5 million
|
3/7/2019 | CV | Market Commentary: Pluralsight convertibles dominate secondary, expand on debut; Exact Sciences keeps expanding
|
3/7/2019 | CV | Market Commentary: Morning Commentary: Pluralsight convertibles dominate secondary, trade up on debut
|
3/6/2019 | CV | Market Commentary: Pluralsight on tap; Ares Capital wrapped around issue price; Exact Sciences expands
|
3/6/2019 | CV | Market Commentary: Morning Commentary: Ares Capital, Exact Sciences price convertible notes at discounts
|
3/6/2019 | BKCVIG | Moody's rates Ares Capital notes Baa3
|
3/6/2019 | CV | New Issue: Ares Capital prices $350 million 4.625% convertible notes due 2024 at 98, up 15%
|
3/5/2019 | CV | Market Commentary: Exact Sciences on tap; Pluralsight looks cheap; Ares Capital reprices; Ctrip.com in focus
|
3/5/2019 | BKCVIG | S&P rates Ares Capital convertibles BBB-
|
3/5/2019 | BKCVHY | Fitch rates Ares convertibles BBB
|
3/5/2019 | CV | Market Commentary: Morning Commentary: Pluralsight, Ares Capital offer combined $800 million convertibles
|
3/5/2019 | CV | Ares Capital talks $350 million five-year convertible notes to yield 4.125%-4.625%, up 15%-20%
|
1/7/2019 | CV | Market Commentary: Convertibles secondary tone improves; Ares Capital dominates trading; biotechs strong
|
1/7/2019 | CV | Market Commentary: Morning Commentary: Ares Capital continues to dominate trading; biotech tape strong
|
1/2/2019 | CV | Market Commentary: Short-duration paper in focus; Ares eyed; Tesla tumbles outright, holds dollar-neutral
|
1/2/2019 | CV | Market Commentary: Morning Commentary: Convertibles open year with decent trading volume; Ares Capital eyed
|
10/15/2018 | CV | Market Commentary: Tilray convertibles rebound, trade above par; cannabis sector eyed; Ares Capital active
|
10/15/2018 | CV | Market Commentary: Morning Commentary: Ares Capital convertibles see high trading volume; Tilray rebounds
|
10/3/2018 | BKCVIG | Moody's upgrades Ares Capital
|
8/20/2018 | CV | Market Commentary: MercadoLibre, Cree on tap; new Illumina convertibles expand; Ares Capital notes active
|
8/20/2018 | CV | Market Commentary: Morning Commentary: Illumina holds; Ares Capital leads trading; Canopy Growth climbs
|
7/2/2018 | CV | Market Commentary: Convertible space takes a break ahead of holiday; Zillow, Ares active; Tesla volatile
|
6/26/2018 | BKCVIG | Moody's may upgrade Ares Capital
|
6/25/2018 | BKCVIG | S&P lowers Ares Capital
|
6/25/2018 | BKCVIG | Fitch affirms Ares Capital
|
4/3/2018 | BKCVHYIG | S&P acts on business development companies
|
1/9/2018 | CV | Market Commentary: Wheeler to price add on to 8.75% preferreds; Insulet in demand; GoPro holders hold on
|
1/8/2018 | BKCVIG | Fitch to rate Ares Capital debt BBB
|
1/8/2018 | BKCVIG | S&P gives Ares notes BBB
|
11/17/2017 | CV | Market Commentary: Intel call news shakes the market, Scorpio Tankers, Ares Capital see heavy trading volume
|
10/10/2017 | CV | Market Commentary: Morning Commentary: Convertibles mostly quiet; HubSpot dips; Ares notes, shares improve
|
8/7/2017 | BKCVIG | Fitch to rate Ares Capital debt BBB
|
8/7/2017 | BKCVIG | S&P rates Ares notes BBB
|
6/22/2017 | BKCVIG | Moody's: Ares to positive
|
1/30/2017 | CV | Market Commentary: Convertibles weaken with stocks; Ares Capital’s new issue trades sub-par; Greenbrier on tap
|
1/30/2017 | CV | Market Commentary: Morning Commentary: Convertibles weaken with stocks; Ares Capital’s new issue trades below par
|
1/25/2017 | CV | Market Commentary: Ares Capital’s new deal straddles par; Liberty firms; Horizon Global, Virtus deals coming up
|
1/25/2017 | CV | Market Commentary: Morning Commentary: Ares Capital’s new convertibles lose momentum; Horizon’s upcoming deal eyed
|
1/24/2017 | CV | Market Commentary: Ares Capital deal trades over par post-pricing; Horizon Global on tap; Yahoo! active
|
1/24/2017 | CV | Market Commentary: Morning Commentary: Ares Capital deal tops par post-pricing; Yahoo! active, better on results
|
1/24/2017 | CV | New Issue: Ares Capital prices upsized $350 million five-year convertibles to yield 3.75%, up 15%
|
1/23/2017 | CV | Market Commentary: Convertibles muted as week kicks off; Ares Capital bringing five-year paper; Cascadian on tap
|
1/23/2017 | BKCVIGPF | Fitch rates Ares Capital convertibles BBB
|
1/23/2017 | BKCVIG | S&P assigns BBB to Ares Capital convertibles
|
1/23/2017 | CV | Market Commentary: Morning Commentary: Convertibles muted as week kicks off; Ares Capital bringing five-year paper
|
1/23/2017 | CV | Ares Capital offers $250 million five-year convertible notes; price talk 3.25%-3.75%, up 15%-20%
|
9/14/2016 | BKCVIGPF | Fitch: Ares Capital notes BBB
|
9/14/2016 | BKCVIGPF | S&P: Ares Capital notes BBB
|
5/24/2016 | BKCVHY | Moody’s lowers Ares Capital view to negative
|
5/23/2016 | BKCVIG | S&P puts Ares Capital watch
|
3/16/2016 | BKCVHYIGPF | S&P: Negative view for four U.S. development firms
|
1/19/2016 | CV | Market Commentary: Higher-grade convertibles in focus amid better outright sellers; Newmont Mining holds in
|
1/19/2016 | CV | Market Commentary: Morning Commentary: High-grade convertibles strengthen; Newmont Mining bond adds as shares fall
|
12/22/2015 | CV | Market Commentary: Convertibles quiet again; Ares Capital, Intel trade early; SunEdison shares tank
|
12/22/2015 | CV | Market Commentary: Morning Commentary: Convertibles quiet again; light volume focused on Ares Capital, Intel
|
12/21/2015 | CV | Market Commentary: Convertibles quiet to start holiday-shortened week; Whiting drops another point on swap
|
12/11/2015 | CV | Market Commentary: Convertibles down in line with lower equities; Horizon Pharma falters; SunEdison steady
|
12/11/2015 | CV | Market Commentary: Morning Commentary: Convertibles quiet as equities drop; Ares Capital, Restoration Hardware active
|
9/23/2015 | CV | Market Commentary: Convertibles muted by Yom Kippur holiday; high-grade names in focus; Illumina drops
|
9/22/2015 | CV | Market Commentary: Convertibles, broader markets drop; Weatherford deal pulled, stock rebounds; biotechs down
|
9/22/2015 | CV | Market Commentary: Morning Commentary: Weatherford deal pulled, stock pops back; Ares Capital bonds active
|
5/4/2015 | CV | Market Commentary: New Source launches; Isis adds on swap; Ares Capital steady to mixed after earnings miss
|
5/4/2015 | CV | Market Commentary: Morning Commentary: Ares Capital steady after earnings miss; Priceline trades a little higher
|
3/13/2015 | BKCVIG | Fitch revises Ares Capital to positive
|
11/18/2014 | BKCVIG | Fitch to rate Ares Capital debt BBB
|
11/18/2014 | BKCVIG | S&P assigns BBB to Ares notes
|
11/17/2014 | CV | Market Commentary: Three deals launch early in primary; fourth deal follows after the close; secondary quiet
|
10/20/2014 | CV | Market Commentary: Convertibles market players watching for next trend; Ares Capital, American Realty better
|
10/20/2014 | CV | Market Commentary: Morning Commentary: Ares Capital, American Realty Capital trading better; Peabody Energy quiet
|
8/5/2014 | CV | Market Commentary: Convertibles weaker; Cobalt ‘comes in’ on hedge after earnings miss; Endeavour lower
|
6/20/2014 | BKCVHYIG | S&P assigns Ares revolver BBB
|
6/10/2014 | CV | Market Commentary: Morning Commentary: Ares Capital trades actively, in line; SanDisk lower outright after downgrade
|
3/7/2014 | CV | Market Commentary: Midday Commentary: Convertibles quiet; older Encore up with shares; Salesforce in line with stock
|
3/7/2014 | CV | Market Commentary: Convertibles quiet; Teslas lower outright, mixed on hedge in active trade; older Encore up
|
1/23/2014 | BKCVHYIG | S&P: Ares Capital unchanged after add-on
|
12/10/2013 | CV | Market Commentary: Post, Finisar deals get mixed reviews; Ares adds on hedge; Yandex, E-House, Trulia launch
|
11/15/2013 | BKCVHYIG | S&P gives Ares Capital notes BBB
|
11/12/2013 | BKCVIG | Fitch to rate Ares debt BBB
|
10/14/2013 | CV | Market Commentary: Convertibles little moved amid holiday; Liberty Media, Ares flat; Resource Capital on tap
|
7/29/2013 | CV | Market Commentary: Saks jumps outright on buyout news; Tesla paper flat; Group 1 trades; Vantage Drilling up
|
7/19/2013 | CV | Ares Capital greenshoe lifts 4.375% convertible sale to $300 million
|
7/19/2013 | CV | Market Commentary: New Jakks quiet; existing Jakks trades lower; Ares gets boost from research; AMD gains
|
7/17/2013 | CV | Market Commentary: Jakks plans new issue; secondary trades quietly; Ares, Forest City mixed; Volcano edging up
|
7/16/2013 | CV | Market Commentary: New Ares slips from discounted price; Forest City gains; Affiliated dips on company call
|
7/16/2013 | CV | New Issue: Ares sells $250 million 4.375% 5.5-year convertibles at discount of 98.5, up 15%
|
7/15/2013 | BKCVIG | S&P: Ares Capital convertibles BBB
|
7/15/2013 | BKCVIG | Fitch: Ares Capital convertibles BBB
|
7/15/2013 | CV | Ares Capital plans $250 million of 5.5-year convertibles at discount with coupon of 4.125%-4.375%, up 15%
|
7/15/2013 | CV | Market Commentary: No big jump for Leap; Merrimack extends gains; Ares Capital on tap again; Forest City to price
|
4/8/2013 | CV | Market Commentary: Medtronic convertibles trade ahead of maturity; Alcoa flat to up a hair; Colony gains
|
11/7/2012 | CV | Market Commentary: Convertibles drop in line with equity sell-off; planned iStar offering looks fair to cheap
|
11/7/2012 | CV | New Issue: Ares prices $40 million convertibles in add-on to 4.75% notes due 2018, up 15.9%
|
10/10/2012 | BKCVIG | Fitch rates Ares Capital convertibles BBB
|
10/10/2012 | CV | Ares greenshoe fully exercised, lifting convertibles to $230 million
|
10/5/2012 | CV | Market Commentary: Convertibles mostly quiet; WellPoint puts in notably strong week; Home Inns drops on swap
|
10/4/2012 | CVIGPF | Fitch rates Ares Capital convertibles BBB
|
10/4/2012 | CV | New Issue: Ares sells $200 million 5.25-year convertibles at 99.25 with 4.75% coupon, up 17.5%
|
10/4/2012 | CV | Market Commentary: New Ares Capital flat after pricing at discount; WellPoint gains; NuVasive loses on hedge
|
10/3/2012 | CV | Ares Capital plans $200 million 5.25-year convertibles to yield 4.25%-4.75%, up 17.5%-22.5%
|
10/3/2012 | CV | Market Commentary: New WellPoint up on debut; Ares Capital on tap; existing Ares paper quiet; NuVasive drops
|
9/25/2012 | BKCVIG | Fitch rates Ares notes BBB
|
9/20/2012 | CVIGPF | Fitch: Ares Capital notes BBB
|
6/13/2012 | CVIGPF | S&P: Ares Capital to stable
|
5/16/2012 | CV | Market Commentary: Patriot Coal extends sharp fall; U.S. Steel lower on economic worries, Einhorn comments
|
3/14/2012 | CV | Ares greenshoe exercised in part, lifts convertibles to $162.5 million
|
3/13/2012 | CVIGPF | Fitch rates Ares notes BBB
|
3/9/2012 | CV | New Issue: Ares Capital prices $150 million five-year convertibles to yield 4.875%, up 17.5%
|
3/9/2012 | CV | Market Commentary: Ares puts in lackluster debut; Priceline comes 'in' slightly; Molycorp deal pushes stock
|
3/8/2012 | CV | Ares Capital talks $150 million five-year convertibles at 4.375%-4.875%, up 17.5%-20%
|
3/8/2012 | CV | Market Commentary: Navistar weaker on hedge after outlook cut; Dendreon drops 2 points on positive J&J drug study
|
1/27/2012 | CVIG | Fitch assigns Ares notes BBB
|
9/30/2011 | CV | Market Commentary: Convertibles sell off; GMX, MGM trade lower; Kodak drops sharply on restructuring fears
|
6/20/2011 | CV | Market Commentary: Clearwire drops on Sprint linkup talk; Kodak steady ahead of ITC ruling; Sino-Forest lower
|
6/17/2011 | CV | Market Commentary: Convertibles mostly soften; Clearwire down; China Sunergy offered at 52; KV Pharma active
|
6/14/2011 | BKCVIG | S&P ups ARES to positive
|
6/3/2011 | CV | Market Commentary: Sino-Forest drops off a cliff outright, but adds on hedge; Ares, Superior Energy trade
|
6/3/2011 | CVIGPF | Ares files $2 billion shelf registration for preferreds, debt, stock
|
4/26/2011 | CV | Market Commentary: Apollo pulls planned deal; MGM moves down in line to weaker; market players eye earnings
|
4/7/2011 | CV | Market Commentary: New Fifth Street trades around par; Newmont Mining active, slightly better dollar neutral
|
4/6/2011 | CV | Market Commentary: Fifth Street intends to price $150 million notes; Amerigroup, SM Energy paper cheapening
|
3/29/2011 | CV | Market Commentary: Goodyear slips; InterDigital up in gray; Mentor on tap; A123 short on borrow; Vertex rises
|
3/28/2011 | CV | Ares greenshoe exercised; 5.125% convertibles lifted to $230 million
|
3/24/2011 | CV | Market Commentary: James River upsizes, jumps on debut; Ares, Gilead add to gains; Best Buy slips with earnings
|
3/23/2011 | BKCVIG | Fitch rates Ares convertibles BBB
|
3/23/2011 | CV | Market Commentary: Ares, Photronics jump on debuts; Gilead gains on deal; James River up in gray; Kinross up
|
3/22/2011 | CV | Ares Capital talks $200 million five-year convertible notes to yield 4.875%-5.375%, up 15%-20%
|
3/22/2011 | CV | New Issue: Ares prices $200 million of five-year convertibles at 5.125%, up 17.5%
|
3/22/2011 | CVIGPF | Fitch: Ares convertibles BBB
|
2/11/2011 | CV | Market Commentary: Molycorp drops; called Ford preferreds 'come in' a couple of points; Wright Medical jumps
|
1/28/2011 | CV | Ares greenshoe lifts 5.75% convertibles due 2016 to $575 million
|
1/20/2011 | CV | Market Commentary: Ares Capital, Apollo mostly flat on debuts; Apollo remarketed at 98.5; MannKind plunges
|
1/20/2011 | CVIGPF | Fitch: Ares convertibles BBB
|
1/19/2011 | CV | Market Commentary: Ares Capital notes upsized, terms revised; MGIC down on earnings miss; Radian, PMI drop
|
1/19/2011 | BKCVHYIG | Fitch to rate Ares notes BBB
|
1/19/2011 | CV | New Issue: Ares Capital prices upsized $500 million five-year convertibles to yield 5.75%, up 17.5%
|
1/18/2011 | CV | Ares Capital talks $300 million five-year convertibles at 5.75%-6.25%, up 17.5%-22.5% for Wednesday
|
1/18/2011 | CV | Market Commentary: Dendreon firm on stock outlook; Kinross maintains guidance; Symantec upgraded; Ares plans deal
|